Twist Bioscience Corporation (TWST)
NMS – Real Time Price. Currency in USD
121.78
-1.34 (-1.09%)
Market open: Aug 12, 2026, 10:02 AM EDT
123.08
-0.04 (-0.03%)
Previous after-hours: Aug 11, 2026, 7:54 PM EDT
Find any stock by ticker or company name

NMS – Real Time Price. Currency in USD
121.78
-1.34 (-1.09%)
Market open: Aug 12, 2026, 10:02 AM EDT
123.08
-0.04 (-0.03%)
Previous after-hours: Aug 11, 2026, 7:54 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $117.4M significantly exceed its total debt $93.6M, ensuring strong financial flexibility
Total current assets $321.3M exceed Total current liabilities $120.3M, highlighting excellent liquidity
Debt-to-equity ratio (0.2) is well below the industry average (-0.1), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$8.6M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 2.67 | 2.46 | 10 | |
| Quick ratio | 2.38 | 2.06 | 10 | |
| Debt to Equity | 0.21 | -0.13 | 9.0 | |
| Debt to Assets | 0.14 | 1.87 | 8.0 | |
| Interest coverage | N/A | 4.31 | 1.0 | |
| Weighted average score | 7.6 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 204M | 245M | 313M | 377M | 432M |
| Gross Profit | 84M | 90M | 133M | 191M | 224M |
| Operating Income | -249M | -207M | -176M | -136M | -138M |
| Net Income | -218M | -205M | -209M | -78M | -137M |
| EBITDA | -212M | -178M | -144M | -111M | -112M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 24.74 | 12.25 | 8.5 |
| Next quarter | 21.11 | 19.29 | 9.5 |
| Current year | 21.18 | -66.14 | 5.5 |
| Next year | 19.29 | 35.08 | 9.5 |
| Weighted average score | 8.3 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 6.92 | 20.38 | 21.13 | 66.01 | 8.8 |
| Y/Y | 23.24 | -271.89 | -269.69 | 18.14 | 5.3 |
| 3y average | 22.81 | 22.29 | 24.93 | 24.93 | 10 |
| 5y average | 33.82 | 2.99 | 11.66 | 4.16 | 6.3 |
| Weighted average score | 7.6 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |